NEW YORK (GenomeWeb) – The US Food and Drug Administration today issued a revised guidance recommending universal testing of donated whole blood and blood components for Zika virus in the US and its territories.

The FDA first issued guidance on Feb. 16 recommending that only areas with active Zika virus transmission screen whole blood and blood components for the virus, use pathogen-reduction devices, or halt blood collection and obtain whole blood and blood components from areas of the US without active virus transmission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.